| A more focused discovery process using proteins as | | | | including the United States, Europe, Asia-Pacific and |
| biomarkers for various diseases has been in the | | | | Rest of World. The regional markets further analyzed |
| development stage for quite some time now. The | | | | for 10 independent countries across Europe – |
| recent years have witnessed a more targeted | | | | Germany, the United Kingdom, France, Italy, Spain, |
| approach in proteomics and biomarker discovery as | | | | Sweden and Rest of Europe; Asia-Pacific –Japan, |
| against a broad exploration of the entire proteome. | | | | China, India, Australia and Rest of Asia-Pacific. |
| As a result, focus on sample preparation has gained in | | | | This 230 page global market report includes 92 rich |
| importance, with researchers devoting more time in | | | | data tables, supported with meaningful and easy to |
| simplifying sample through fractionation and | | | | understand graphical presentation, of market |
| enrichment. This has enabled in more informative data | | | | numbers. The statistical tables represent the data for |
| generated in biomarker discovery experiments. | | | | the global market value by geographic regions, |
| Biomarker discovery technologies analyzed in this | | | | biomarker discovery technologies and therapeutic |
| study include Bioinformatics, Genomics, Molecular | | | | areas. The report also profiles 52 key global players |
| Imaging, Proteomics and Other. The report is also | | | | and 72 major players across the United States – |
| analyses the global market for biomarker therapeutic | | | | 43; Europe – 19; Asia-Pacific – 4; and Rest of |
| areas comprising Cardiology, Neurology, Oncology and | | | | World – 2. The report also provides the listing of |
| Other.The global market for biomarkers is projected | | | | the companies engaged in research and development, |
| to reach US$26.5 billion by 2015, growing by a sturdy | | | | equipment manufacturing, processing, supplies and |
| CAGR of 20.2% during the period 2007-2015. | | | | distribution of biomarkers. The global list covers the |
| The study reviews and analyses the worldwide | | | | addresses, contact numbers and the website |
| market for Biomarkers. Rich statistical analysis is | | | | addresses of 212 companies. |
| carried out for the global and the regional markets | | | | |